Track topics on Twitter Track topics that are important to you
Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces today that its CEO, Kim Thompson, was recently recognized as one of MyTechMag magazine’s top 20 pioneering CEOs of 2019. In the recent CEO edition, Mr. Thompson shares the incredible story of the founding of Kraig Labs, as well as how his outsider status and determination delivered success against overwhelming odds.
In selecting the top 20 pioneering CEOs of 2019, MyTechMag selection criteria included a review of the complexity of the challenges overcome, the growth of the underlying business, and the CEO’s ability to harness their team’s potential.
“I am honored to have been selected for this recognition. MyTechMag’s award comes on the verge of a very exciting time for Kraig Labs, as we expect to soon be formally launching commercial scale production of our eco-friendly recombinant spider silk,” said CEO and Founder, Thompson. “Kraig Labs has been pioneering the way forward for cost-effective spider silk production and today’s recognition of my work and our Company’s role in bringing this innovation to market is an honor. Together, our team has faced and concurred numerous obstacles that stood between us and our goal. In that spirit I accept this award as recognition for the entire Kraig Labs team, including our valued employees and shareholders.”
To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news.
About Kraig Biocraft Laboratories, Inc.
The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, LLC
Recombinant DNA is the formation of a novel DNA sequence by the formation of two DNA strands. These are taken from two different organisms. These recombinant DNA molecules can be made with recombinant DNA technology. The procedure is to cut the DNA of ...
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...